1. Home
  2. SDRL vs ANIP Comparison

SDRL vs ANIP Comparison

Compare SDRL & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seadrill Limited

SDRL

Seadrill Limited

HOLD

Current Price

$34.85

Market Cap

2.0B

Sector

Energy

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$85.07

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDRL
ANIP
Founded
2005
2001
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SDRL
ANIP
Price
$34.85
$85.07
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$46.25
$107.33
AVG Volume (30 Days)
768.1K
535.8K
Earning Date
02-25-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.55
1.67
Revenue
$1,307,000,000.00
$826,880,000.00
Revenue This Year
$8.52
$44.37
Revenue Next Year
N/A
$9.83
P/E Ratio
$63.31
$50.65
Revenue Growth
N/A
48.87
52 Week Low
$17.74
$54.10
52 Week High
$38.43
$99.50

Technical Indicators

Market Signals
Indicator
SDRL
ANIP
Relative Strength Index (RSI) 57.07 57.05
Support Level $34.61 $75.10
Resistance Level $36.25 $87.01
Average True Range (ATR) 1.43 3.30
MACD 0.01 0.86
Stochastic Oscillator 48.19 83.29

Price Performance

Historical Comparison
SDRL
ANIP

About SDRL Seadrill Limited

Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, Canada and others. The company derives maximum revenue from the United States.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: